Have your say in peri-/menopause research.
VITAL is the Virtual regIstry of peri-/menopause in AusTrALia.
The VITAL program aims to improve health outcomes across Australia, co-creating real-world impact via knowledge development, research, education and policy.
|
Latest News
In Australia, is Addyi (Flibanserin) available or what is available?
Australia Leads the Way in Androgen Treatment for Women with HSDD While the US-approved drug flibanserin offers limited benefit for Hypoactive Sexual Desire Disorder (HSDD), it’s… Continue Reading →
How Satisfied are you with Your Sex Life?
Let’s Talk About Sexual Satisfaction—It Matters More Than You Think Did you know that 4 in 10 women experience sexual concerns during mid-life? Yet many suffer… Continue Reading →
MHRA approves testosterone cream for UK postmenopausal women
MHRA approves testosterone cream for UK postmenopausal women 12 August 2025 Perth, Australia and Guildford, England: Lawley Pharmaceuticals and its commercial… Continue Reading →